Systematic Alpha Investments, LLC Amgen Inc Transaction History

Systematic Alpha Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $673,604 - $759,703	3,001 New	3,001 $676,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $198 - $227	-1 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $139,914 - $155,224	-599 Reduced 99.83%	1 $0
Q4 2020 Apr 16, 2021	BUY	$216.38 - $257.67 $129,828 - $154,602	600 New	600 $138,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Systematic Alpha Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Systematic Alpha Investments, LLC with notifications on news.